Cross walk - 2022 form changes
HAIC
HAIC: Multi-site Gram-Negative Surveillance Initiative (MuGSI-CRE/CRAB) (Attachment #3)
Note: Change for the updated 2022 CRF are highlighted in yellow.
Question on 2021 form |
Question on 2022 form |
||||||||||||||||||||||||
Patient identifier information
|
Patient identifier information
|
||||||||||||||||||||||||
23c. Chest radiology findings (check all that apply Not done No report available Acute respiratory distress syndrome (ARDS) Air space density/opacity Ground glass opacities/infiltrates Bronchopneumonia/pneumonia Cannot rule out pneumonia Cavitation Consolidation Infiltrate Pleural effusion Nodules |
23c. Chest radiology findings (check all that apply Not done No report available Acute respiratory distress syndrome (ARDS) Air space density/opacity Ground glass opacities/infiltrates Bronchopneumonia/pneumonia Cannot rule out pneumonia Cavitation Consolidation Infiltrate Pleural effusion Nodules No evidence of pneumonia |
||||||||||||||||||||||||
24a. Did the patient have a positive test(s) for SARS-CoV-2 (molecular assay, serology, or other confirmatory test) on or before the DISC? Yes No Unknown |
24a. Did the patient have a positive test(s) for SARS-CoV-2 (molecular assay, serology, or other confirmatory test) in the year before or day of the DISC? Yes No Unknown |
||||||||||||||||||||||||
24b. If yes, complete table below:
|
24b. If yes, complete the table below for the most recent positive SARS-CoV-2 test in the year before or day of the DISC:
|
||||||||||||||||||||||||
29b. CRF Status Complete Pending Chart unavailable after 3 requests |
29b. CRF Status Complete Pending Chart unavailable after 3 requests Complete – Pending Data |
HAIC: Multi-site Gram-Negative Surveillance Initiative ─ Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (MuGSI-ESBL) (Attachment #4)
Note: Change for the updated 2022 CRF are highlighted in yellow.
Question on 2021 form |
Question on 2022 form |
||||||||||||||||||||||||
Patient identifier information
|
Patient identifier information
|
||||||||||||||||||||||||
24b. IF YES, CHECK ALL ANTIMICROBIALS USED IN THE 30 DAYS BEFORE THE DISC: (Check all that apply) □ Unknown
□ Amikacin □ Amoxicillin □ Amoxicillin/clavulanic acid □ Ampicillin □ Ampicillin/sulbactam □ Azithromycin □ Aztreonam □ Cefazolin □ Cefdinir □ Cefepime □ Cefiderocol □ Cefixime □ Cefotaxime □ Cefoxitin □ Cefpodoxime □ Ceftaroline □ Ceftazidime □ Ceftazidime/avibactam □ Ceftizoxime □ Ceftolozane/tazobactam □ Ceftriaxone □ Cefuroxime □ Cephalexin □ Ciprofloxacin □ Clarithromycin □ Clindamycin □ Dalbavancin □ Daptomycin □ Delafloxacin □ Doripenem □ Doxycycline □ Eravacycline □ Ertapenem □ Fidaxomicin □ Fosfomycin □ Gentamicin □ Imipenem/cilastatin □ Levofloxacin □ Linezolid □ Meropenem □ Meropenem/ vaborbactam □ Metronidazole □ Moxifloxacin □ Nitrofurantoin □ Omadacycline □ Oritavancin □ Penicillin □ Piperacillin/tazobactam □ Polymyxin B □ Polymyxin E (colistin) □ Rifaximin □ Tedizolid □ Telavancin □ Tigecycline □ Tobramycin □ Trimethoprim □ Trimethoprim/ sulfamethoxazole □ Vancomycin □ IV □ PO □ Other (specify): _____________________ □ Other (specify): _____________________ |
24b. IF YES, CHECK ALL ANTIMICROBIALS USED IN THE 30 DAYS BEFORE THE DISC: (Check all that apply) □ Unknown
□ Amikacin □ Amoxicillin □ Amoxicillin/clavulanic acid □ Ampicillin □ Ampicillin/sulbactam □ Azithromycin □ Aztreonam □ Cefadroxil □ Cefazolin □ Cefdinir □ Cefepime □ Cefiderocol □ Cefixime □ Cefotaxime □ Cefoxitin □ Cefpodoxime □ Ceftaroline □ Ceftazidime □ Ceftazidime/avibactam □ Ceftizoxime □ Ceftolozane/tazobactam □ Ceftriaxone □ Cefuroxime □ Cephalexin □ Ciprofloxacin □ Clarithromycin □ Clindamycin □ Dalbavancin □ Daptomycin □ Delafloxacin □ Doripenem □ Doxycycline □ Eravacycline □ Ertapenem □ Fidaxomicin □ Fosfomycin □ Gentamicin □ Imipenem/cilastatin □ Levofloxacin □ Linezolid □ Meropenem □ Meropenem/ vaborbactam □ Metronidazole □ Moxifloxacin □ Nitrofurantoin □ Omadacycline □ Oritavancin □ Penicillin □ Piperacillin/tazobactam □ Polymyxin B □ Polymyxin E (colistin) □ Rifaximin □ Tedizolid □ Telavancin □ Tigecycline □ Tobramycin □ Trimethoprim □ Trimethoprim/ sulfamethoxazole □ Vancomycin □ IV □ PO □ Other (specify): _____________________ □ Other (specify): _____________________ |
||||||||||||||||||||||||
25a. Did the patient have a positive test(s) for SARS-CoV-2 (molecular assay, serology, or other confirmatory test) on or before the DISC? ð Yes ð No ð Unknown |
25a. Did the patient have a positive test(s) for SARS-CoV-2 (molecular assay, serology, or other confirmatory test) in the year before or day of the DISC? ð Yes ð No ð Unknown |
||||||||||||||||||||||||
25b. If yes, complete table below:
|
25b. If yes, complete the table below for the most recent positive SARS-CoV-2 test in the year before or day of the DISC:
|
||||||||||||||||||||||||
28b. CRF STATUS: ð Complete ð Complete-Pending ð Pending ð Chart unavailable after 3 requests
|
28b. CRF STATUS: ð Complete ð Complete-Pending ð Pending ð Chart unavailable after 3 requests
|
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Bulens, Sandra N. (CDC/DDID/NCEZID/DHQP) |
File Modified | 0000-00-00 |
File Created | 2021-12-17 |